[DOI] [PubMed] [Google Scholar] 23.Pyo H.K., Yoo H.G., Won C.H., Lee S.H., Kang Y.J., Eun H.C., Cho K.H., Kim K.H
The stable gastric pentadecapeptide BPC 157, an original cytoprotective antiulcer peptide that is used in ulcerative colitis and recently in a multiple sclerosis trial and that has an LD1 that has not been achieved [1,2,3,4,5,6,7,8,9,10,11], is known to have pleiotropic beneficial effects [1,2,3,4,5,6,7,8,9,10,11] and to interact with several molecular pathways [2, 27,28,29,30,31,32]
The goal is not to block patients from learning about emerging therapies
This works when the dose range is narrow and lands on convenient unit marks, but community sources note that measurement errors at high concentrations have proportionally larger consequences
But both can be prescribed for other off-label uses
Make sure you understand the conditions, especially around opened vs unopened products